ADDvise Group acquires MRC Systems FZE - Regulatory information

16-02-2021   Regulatory press release

ADDvise Group AB (publ) ("ADDvise") has entered into a share purchase agreement with the shareholders of MRC Systems FZE (the "Company" and "MRC") regarding an acquisition of 100 percent of the shares in the Company (the "Acquisition").

MRC develops and manufactures cleanrooms for the pharmaceutical industry and hospitals. The Company has its headquarters and production facility located in Dubai. The Company currently employs around 110 people.

The initial purchase price amounts to USD 5 million. In addition to the initial purchase price, additional earn-outs of maximum USD 3 million in total can be paid out over a three-year period, given that the sellers achieve certain predetermined targets.

The Company's revenue for the financial year 2019/2020 amounts to USD 9.8 million with an EBITDA of USD 1.10 million. Proforma revenue 2020 for ADDvise including MRC will therefore amount to approximately SEK 439.6 million with an EBITDA of approximately SEK 55.0 million. The Acquisition is financed with own funds.

The closing of the acquisition is expected to take place during the second quarter of 2021, subject to the conditions precedent to closing are met.

Adviser

Mangold Fondkommission AB has acted as financial adviser to ADDvise in the Acquisition. DLA Piper Middle East LLP has acted as legal adviser to ADDvise in the Acquisition.  

For further information, please contact:

Rikard Akhtarzand, VD
+46 765-25 90 71
rikard.akhtarzand@addvisegroup.se

Important information:

This information is by ADDvise Group AB required to disclose under the EU Market Abuse Regulation. The information was submitted for publication on 16 February 2021 at 15:00 CET.
 

Om ADDvise Group
ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of approximately 10 subsidiaries organized into two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business - both geographically and product wise. ADDvise Group's shares are listed on Nasdaq First North Growth Market and Mangold Fondkommission AB, +46 8 503 015 50, CA@mangold.se,is the Company's Certified Adviser. Additional information is available at www.addvisegroup.com.

Latest press releases

Interim report 2025, January 1–June 30

Regulatory

In the second quarter of 2025, organic sales adjusted for currency effects increased, driven by steady demand for laboratory equipment and rental of equipment for clinical studies. Operating cash flow improved in the quarter, and EBITA was in line with last year with a stronger margin. Through the new capital structure, ADDvise’s annual interest expenses…

Invitation to presentation of interim report April 1 – June 30, 2025

Non-regulatory

ADDvise Group publishes its interim report April 1 – June 30, 2025 on Thursday, July 17, 2025 at 7.45 am (CET). Media, investors and analysts are invited to attend a webcast and teleconference on the same day at 14:00 (CET). CEO, Staffan Torstensson, and CFO, Johan Irwe, will present the report. Webcast If you wish to…

ADDvise announces that the conditions for early redemption of outstanding secured bonds have been fulfilled

Regulatory

ADDvise Group AB (publ) (“ADDvise” or the “Company”) announced on 14 May 2025 that ADDvise intends to redeem the Company’s outstanding senior secured bonds with ISIN SE0020180271 and ISIN NO0013180786 (the “Early Redemption”). The Early Redemption was conditional upon the entering into of the new secured facilities agreement of the equivalence of SEK 450 million…